Hangzhou Tigermed Consulting (03347) completes the sale of all issued shares of Shanghai Guanhe Pharmaceutical.
Tiger Pharmaceuticals (03347) announced the sale of all issued shares of Shanghai Guanhe Pharmaceutical Technology Co., Ltd. (the target company). All preconditions specified in the share transfer agreement have been met, and the sale was completed on March 3, 2026, in accordance with the terms and conditions of the share transfer agreement. Following the completion of the sale, the target company and its subsidiaries (referred to as the "target group") will remain subsidiaries of the company. The financial performance of the target group will be consolidated into the financial statements of the Fanda Group. Since the sale is considered an internal transaction within the group, it will not have any significant impact on the overall financial position of the group.
Hangzhou Tigermed Consulting (03347) announced the sale of all issued shares of Shanghai Guanhe Pharmaceutical Technology Co., Ltd. (the target company). All the conditions precedent in the share transfer agreement have been met, and the sale will be completed on March 3, 2026, in accordance with the terms and conditions of the share transfer agreement. After the completion of the sale, the target company and its subsidiaries (referred to as the "target group") will continue to be subsidiaries of the company. The financial performance of the target group will be consolidated into the financial statements of the Fangda Group. As the sale is an internal transaction of the group, it will not have any significant impact on the comprehensive financial statements of the group.
Related Articles
As of the end of February, Montage Technology (06809) has cumulatively repurchased 1.662 million A-shares.
JD INDUSTRIALS (07618) releases exclusive scenario solutions to build a high-quality upgrade for the liquor manufacturing industry.
SINOPEC CORP(00386) A-shares experienced abnormal fluctuations in stock trading, and there are no significant undisclosed matters that should have been disclosed.
As of the end of February, Montage Technology (06809) has cumulatively repurchased 1.662 million A-shares.
JD INDUSTRIALS (07618) releases exclusive scenario solutions to build a high-quality upgrade for the liquor manufacturing industry.
SINOPEC CORP(00386) A-shares experienced abnormal fluctuations in stock trading, and there are no significant undisclosed matters that should have been disclosed.
RECOMMEND
